tert-Butyl 4-bromo-3-methyl-1H-pyrazole-1-carboxylate, 95.0%, 250mg

(R)-3-(Pyrrolidin-2-yl)phenol hydrochloride, 95.0%, 100mg

tert-Butyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetate, 98%, 1g

8a-phenyl-octahydropyrrolo[1,2-a]pyrimidine, 95.0%, 2g

TRIS, 25 kg

N,N-Dibenzylethenesulfonamide, 95%, 500mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)dibenzothiophene>98.0%(GC)(T)1g

(5-Methyl-2-propoxyphenyl)boronic acid, 95.0%, 250mg

(R)-2-Amino-3-(m-tolyl)propanoic acid, 95.0%, 1g

Pentaerythritol Tetra(3-mercaptopropionate)>90.0%(T)500mL

(5-Bromopyrazin-2-yl)methanol, 97%, 1g

Z-Ser-OH, 98%, 5g

Tris(3-hydroxypropyltriazolylmethyl)amine, min. 95%, 5 mg, plastic packaging.